| 发明名称 |
ENZASTAURIN FOR THE TREATMENT OF CANCER |
| 摘要 |
The present invention relates to HDAC2 as a biological marker for treating cancer in a patient using Enzastaurin as a single agent or in combination with a Class I selective HDAC inhibitor. |
| 申请公布号 |
WO2010074936(A2) |
申请公布日期 |
2010.07.01 |
| 申请号 |
WO2009US66925 |
申请日期 |
2009.12.07 |
| 申请人 |
ELI LILLY AND COMPANY;GANJI, GOPINATH |
发明人 |
GANJI, GOPINATH |
| 分类号 |
A61K31/445 |
主分类号 |
A61K31/445 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
